Charter Research & Investment Group Inc. acquired a new position in shares of Varian Medical Systems, Inc. (NYSE:VAR) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 5,470 shares of the medical equipment provider’s stock, valued at approximately $620,000.
A number of other institutional investors also recently bought and sold shares of VAR. Pearl River Capital LLC purchased a new stake in Varian Medical Systems during the 4th quarter worth about $28,000. First Personal Financial Services increased its position in Varian Medical Systems by 58.8% during the 4th quarter. First Personal Financial Services now owns 351 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 130 shares in the last quarter. Moody National Bank Trust Division purchased a new stake in Varian Medical Systems during the 4th quarter worth about $49,000. Financial Gravity Companies Inc. purchased a new stake in Varian Medical Systems during the 4th quarter worth about $49,000. Finally, Enlightenment Research LLC purchased a new stake in Varian Medical Systems during the 4th quarter worth about $57,000. Hedge funds and other institutional investors own 91.95% of the company’s stock.
A number of analysts have issued reports on VAR shares. Jefferies Financial Group raised their price target on Varian Medical Systems to $145.00 and gave the stock a “buy” rating in a research note on Thursday, January 24th. Barrington Research reissued a “buy” rating on shares of Varian Medical Systems in a research note on Thursday, January 24th. Zacks Investment Research raised Varian Medical Systems from a “hold” rating to a “strong-buy” rating and set a $146.00 price target on the stock in a research note on Saturday, January 26th. Citigroup decreased their price target on Varian Medical Systems from $145.00 to $131.00 and set a “buy” rating on the stock in a research note on Wednesday, January 2nd. Finally, Royal Bank of Canada raised their price target on Varian Medical Systems to $130.00 and gave the stock a “sector perform” rating in a research note on Thursday, January 24th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $130.63.
In other news, insider Kolleen T. Kennedy sold 2,225 shares of Varian Medical Systems stock in a transaction dated Tuesday, February 19th. The stock was sold at an average price of $131.60, for a total value of $292,810.00. Following the transaction, the insider now directly owns 28,581 shares of the company’s stock, valued at approximately $3,761,259.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Gary E. Bischoping, Jr. sold 300 shares of Varian Medical Systems stock in a transaction dated Friday, February 15th. The shares were sold at an average price of $131.69, for a total value of $39,507.00. Following the completion of the transaction, the chief financial officer now directly owns 1,916 shares in the company, valued at $252,318.04. The disclosure for this sale can be found here. Insiders sold a total of 47,466 shares of company stock worth $6,105,577 over the last ninety days. Corporate insiders own 0.74% of the company’s stock.
Shares of NYSE:VAR opened at $136.31 on Friday. Varian Medical Systems, Inc. has a 12-month low of $101.42 and a 12-month high of $137.67. The stock has a market capitalization of $12.35 billion, a price-to-earnings ratio of 30.84, a price-to-earnings-growth ratio of 3.60 and a beta of 0.85.
Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings results on Wednesday, January 23rd. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.01). Varian Medical Systems had a return on equity of 26.18% and a net margin of 12.28%. The business had revenue of $741.00 million during the quarter, compared to analyst estimates of $717.83 million. During the same period in the previous year, the business posted $1.06 earnings per share. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. Equities analysts predict that Varian Medical Systems, Inc. will post 4.7 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: “5,470 Shares in Varian Medical Systems, Inc. (VAR) Purchased by Charter Research & Investment Group Inc.” was originally posted by Highlight Press and is owned by of Highlight Press. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://highlightpress.com/2019/03/15/5470-shares-in-varian-medical-systems-inc-var-purchased-by-charter-research-investment-group-inc.html.
About Varian Medical Systems
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.
Featured Story: Net Margin – Understanding the Different Kinds of Profit
Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.